MIR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1587-1596

  Wang, Yuanyuan ^a   Feng, Jianfang ^b   Zang, Wenqiao ^a   Du, Yuwen ^a   Chen, Xiaonan ^a   Sun, Qianqian ^a   Dong, Ziming ^a,c   Zhao, Guoqiang ^a,c  

^a ZHENGZHOU UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Department of Respiratory Diseases and Clinical Medicine   (China)

Author keywords

Cisplatin sensitivity; DNA polymerase ; Esophageal carcinoma; MIR 499

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CISPLATIN; DNA DIRECTED DNA POLYMERASE BETA; MICRORNA; MICRORNA 499; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN499 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CARCINOMA CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; INVESTIGATIVE PROCEDURES; LUCIFERASE ASSAY; PRIORITY JOURNAL; TREATMENT DURATION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE, TUMOR; CISPLATIN; DNA POLYMERASE BETA; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE, INBRED BALB C; MICRORNAS; MOLECULAR SEQUENCE DATA;

EID: 84936931794     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430321     Document Type: Article

References (45)

1. Ambros V: The functions of animal microRNAs. Nature 2004;431:350-355.
2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
3. Farazi TA, Spitzer JI, Morozov P, Tuschl T: miRNAs in human cancer. J Pathol 2011;223:102-115.
4. Kim VN, Nam JW: Genomics of microRNA. Trends Genet 2006;22:165-173.
5. Kwak PB, Iwasaki S, Tomari Y: The microRNA pathway and cancer. Cancer Sci 2010;101:2309-2315.
6. Zamore PD, Haley B: Ribo-gnome: The big world of small RNAs. Science 2005;309:1519-1524.
7. Brennecke J, Cohen SM: Towards a complete description of the microRNA complement of animal genomes. Genome Biol 2003;4:228.
8. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A: The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005;102:19075-19080.
9. Jensen RH, Tiirikainen M, You L, Ginzinger D, He B, Uematsu K, Xu Z, Treseler P, McCormick F, Jablons DM: Genomic alterations in human mesothelioma including high resolution mapping of common regions of DNA loss in chromosome arm 6q. Anticancer Res 2003;23:2281-2289.
10. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-854.
11. Wightman B, Ha I, Ruvkun G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993;75:855-862.
12. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005;65:7065-7070.
13. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299:425-436.
14. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198.
15. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.
16. Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, Yin L, Wang Y: miRNA-183 Suppresses Apoptosis and Promotes Proliferation in Esophageal Cancer by Targeting PDCD4. Mol Cells 2014;37:873-880.
17. Wu W, Hou W, Wu Z, Wang Y, Yi Y, Lin W: [miRNA-144 in the saliva is a genetic marker for early diagnosis of esophageal cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2013;33:1783-1786.
18. Cao XF, Li SQ: [Role of miRNA in the diagnosis, prognosis and treatment of esophageal cancer]. Zhonghua Zhong Liu Za Zhi 2011;33:161-164.
19. Goodman MF: Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu Rev Biochem 2002;71:17-50.
20. Nowak R, Woszczynski M, Siedlecki JA: Changes in the DNA polymerase beta gene expression during development of lung, brain, and testis suggest an involvement of the enzyme in DNA recombination. Exp Cell Res 1990;191:51-56.
21. Krahn JM, Beard WA, Wilson SH: Structural insights into DNA polymerase beta deterrents for misincorporation support an induced-fit mechanism for fidelity. Structure 2004;12:1823-1832.
22. Prasad R, Batra VK, Yang XP, Krahn JM, Pedersen LC, Beard WA, Wilson SH: Structural insight into the DNA polymerase beta deoxyribose phosphate lyase mechanism. DNA Repair (Amst) 2005;4:1347-1357.
23. Friedberg EC: DNA damage and repair. Nature 2003;421:436-440.
24. Kidane D, Jonason AS, Gorton TS, Mihaylov I, Pan J, Keeney S, de Rooij DG, Ashley T, Keh A, Liu Y, Banerjee U, Zelterman D, Sweasy JB: DNA polymerase beta is critical for mouse meiotic synapsis. EMBO J 2010;29:410-423.
25. Wilson TE, Lieber MR: Efficient processing of DNA ends during yeast nonhomologous end joining. Evidence for a DNA polymerase beta (Pol4)-dependent pathway. J Biol Chem 1999;274:23599-23609.
26. Neijenhuis S, Verwijs-Janssen M, Kasten-Pisula U, Rumping G, Borgmann K, Dikomey E, Begg AC, Vens C: Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase beta. DNA Repair (Amst) 2009;8:336-346.
27. Neijenhuis S, Verwijs-Janssen M, van den Broek LJ, Begg AC, Vens C: Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}. Cancer Res 2010;70:8706-8714.
28. Vens C, Hofland I, Begg AC: Involvement of DNA polymerase beta in repair of ionizing radiation damage as measured by in vitro plasmid assays. Radiat Res 2007;168:281-291.
29. Scanlon KJ, Kashani-Sabet M, Miyachi H: Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest 1989;7:581-587.
30. Bergoglio V, Pillaire MJ, Lacroix-Triki M, Raynaud-Messina B, Canitrot Y, Bieth A, Gares M, Wright M, Delsol G, Loeb LA, Cazaux C, Hoffmann JS: Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res 2002;62:3511-3514.
31. Cabelof DC, Guo Z, Raffoul JJ, Sobol RW, Wilson SH, Richardson A, Heydari AR: Base excision repair deficiency caused by polymerase beta haploinsufficiency: Accelerated DNA damage and increased mutational response to carcinogens. Cancer Res 2003;63:5799-5807.
32. Subramani R, Lopez-Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R: Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS One 2014;9:e97016.
33. Ma Y, Xia H, Liu Y, Li M: Silencing MIR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt. Biomed Res Int 2014;2014:617868.
34. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
35. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841.
36. Li M, Zang W, Wang Y, Ma Y, Xuan X, Zhao J, Liu L, Dong Z, Zhao G: DNA polymerase beta mutations and survival of patients with esophageal squamous cell carcinoma in Linzhou City, China. Tumour Biol 2014;35:553-559.
37. Li M, Zang W, Wang Y, Li Y, Ma Y, Wang N, Tang Y, Liu L, Dong Z, Zhao G: DNA polymerase beta promoter mutations and transcriptional activity in esophageal squamous cell carcinoma. Tumour Biol 2013;34:3259-3263.
38. Hiwasa T, Tokita H, Ike Y: Differential chemosensitivity in oncogene-transformed cells. J Exp Ther Oncol 1996;1:162-170.
39. Vogt U, Falkiewicz B, Bielawski K, Bosse U, Schlotter CM: Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay. Acta Biochim Pol 2000;47:157-164.
40. Falkiewicz B, Schlotter CM, Bosse U, Bielawski K, Vogt U: c-myc oncogene gene dosage, serum CEA and CA-15. 3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer. Acta Biochim Pol 2000;47:149-156.
41. Schickel R, Boyerinas B, Park SM, Peter ME: MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008;27:5959-5974.
42. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X, Li B, Meng X, Ma X, Luo M, Shao K, Li N, Qiu B, Mitchelson K, Cheng J, He J: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008;68:26-33.
43. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866.
44. Li W, Jiang G, Zhou J, Wang H, Gong Z, Zhang Z, Min K, Zhu H, Tan Y: Down-regulation of MIR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem 2014;34:1466-1476.
45. Zhu Y, Xia Y, Niu H, Chen Y: MIR-16 induced the suppression of cell apoptosis while promote proliferation in esophageal squamous cell carcinoma. Cell Physiol Biochem 2014;33:1340-1348.